Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-volume PEG-CS plus bisacodyl vs conventional bowel preparation in high-risk patients
2011-002188-58Phase 4Completed
- Sponsor
- Promefarm
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of macrogol 4000 in chronic constipation and None (2 arms), sponsored by Promefarm. Primary endpoint: Quality of colon cleansing (Ottawa scale). Started Dec 2011; status: completed.
02
Drugs
macrogol 4000
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2011-002188-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002188-58.